Schonfeld Strategic Advisors’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.89M | Buy |
+228,862
| New | +$3.89M | 0.03% | 592 |
|
|
2025
Q1 | – | Sell |
-15,531
| Closed | -$385K | – | 2073 |
|
|
2024
Q4 | $385K | Buy |
15,531
+5,514
| +55% | +$137K | ﹤0.01% | 1448 |
|
|
2024
Q3 | $245K | Sell |
10,017
-20,500
| -67% | -$502K | ﹤0.01% | 1595 |
|
|
2024
Q2 | $715K | Sell |
30,517
-18,181
| -37% | -$426K | ﹤0.01% | 1222 |
|
|
2024
Q1 | $1.61M | Buy |
48,698
+23,193
| +91% | +$766K | 0.01% | 900 |
|
|
2023
Q4 | $694K | Sell |
25,505
-51,567
| -67% | -$1.4M | ﹤0.01% | 1097 |
|
|
2023
Q3 | $1.85M | Buy |
77,072
+2,168
| +3% | +$52.1K | 0.01% | 738 |
|
|
2023
Q2 | $2.39M | Buy |
74,904
+40,839
| +120% | +$1.3M | 0.02% | 693 |
|
|
2023
Q1 | $1.04M | Buy |
34,065
+13,665
| +67% | +$418K | 0.01% | 933 |
|
|
2022
Q4 | $798K | Buy |
20,400
+4,869
| +31% | +$190K | 0.01% | 1261 |
|
|
2022
Q3 | $739K | Sell |
15,531
-42,369
| -73% | -$2.02M | 0.01% | 1460 |
|
|
2022
Q2 | $2.24M | Buy |
+57,900
| New | +$2.24M | 0.02% | 658 |
|
|
2022
Q1 | – | Sell |
-12,260
| Closed | -$977K | – | 2384 |
|
|
2021
Q4 | $977K | Buy |
12,260
+5,952
| +94% | +$474K | 0.01% | 893 |
|
|
2021
Q3 | $549K | Buy |
6,308
+4,308
| +215% | +$375K | 0.01% | 1142 |
|
|
2021
Q2 | $257K | Buy |
+2,000
| New | +$257K | ﹤0.01% | 1498 |
|